We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FBU:NZXFletcher Building Limited Analysis

Data as of 2026-07-03 - not real-time

A$2.76

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Fletcher Building posted flat revenue and a negative profit margin in H1 FY2026, with trailing EPS of -$0.19 but a forward EPS of $0.146, indicating a potential earnings rebound. The stock trades at $2.76, just above the DCF‑derived fair value of $2.72 and sits near the technical resistance of $2.82, while the 20‑day SMA (2.69) sits above the 50‑day SMA (2.55) but below the 200‑day SMA (2.84), suggesting a short‑term pullback within a longer‑term downtrend. Momentum indicators are mixed: RSI at 58.8 points to modest bullish pressure, yet the MACD histogram is negative and the signal line is bearish, and volume is trending lower, underscoring weakening participation. Balance‑sheet stress is evident with a debt‑to‑equity ratio of 68.6% and negative free cash flow, while the company carries no dividend. The high 30‑day volatility (~28%) and low beta (~0.3) reflect a stock that can swing sharply on news but is relatively insulated from market moves. Overall, the share is priced close to analyst targets (median $2.73) but faces upside limited by structural challenges and a tight valuation cushion.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near resistance with bearish MACD
  • Decreasing volume and high short‑term volatility
  • Negative earnings and cash flow

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Forward EPS turning positive
  • Fair valuation relative to DCF and analyst targets
  • High leverage requiring debt reduction

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Potential earnings recovery and stable cash generation from core building products
  • Low beta offering defensive characteristics in a cyclical sector
  • Undervalued book value (P/B ~0.99) providing a margin of safety

Key Metrics & Analysis

Financial Health

Revenue Growth0.50%
Profit Margin-4.22%
P/E Ratio18.9
ROE-6.04%
ROA2.93%
Debt/Equity68.64
P/B Ratio1.0
Op. Cash FlowA$570.0M
Free Cash FlowA$-47625000

Technical Analysis

TrendNeutral
RSI58.8
SupportA$2.50
ResistanceA$2.82
MA 20A$2.69
MA 50A$2.55
MA 200A$2.84
MACDBearish
VolumeDecreasing
Fear & Greed Index93.04

Valuation

Fair ValueA$2.72
Target PriceA$2.78
Upside/Downside0.60%
GradeFair
TypeBlend

Risk Assessment

Beta0.29
Volatility27.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.